Physician

Adam Craig Janot, M.D.

According to 2025 Medicare claims, Adam Janot, M.D. (NPI: 1861767147) practices ophthalmology in the Alexandria, LA market, with the plurality of this provider's patient population coming from Rapides, LA. This provider's primary affiliated billing organization is VITREORETINAL INSTITUTE, A MEDICAL CORPORATION (NPI: 1649226580; TIN: 721037444) and primary practice location at 71301-8423.

Janot's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,730 traditional Medicare patients, billed 51,632 HCPCS/CPT codes, and received $2,920,723 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,062 prescription claims across 667 beneficiaries totaling $213,209 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 40 records totaling $2,718. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $57,048 to $2,920,723. Similarly, Part D prescription costs have moved sharply higher in recent years, from $24,606 to $213,209. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$2.9M2018 Medicare payment: $57,048 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $284,147 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $385,167 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $602,496 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $490,243 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,642,888 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,920,723 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018185522$57,048
20196813,286$284,147
20206933,591$385,167
20219615,312$602,496
20228415,074$490,243
20232,18136,093$1,642,888
20241,73051,632$2,920,723

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$110K$220K2015 Drug cost: $24,606 (USD; Tot_Drug_Cst)2016 Drug cost: $7,694 (USD; Tot_Drug_Cst)2017 Drug cost: $16,122 (USD; Tot_Drug_Cst)2018 Drug cost: $14,281 (USD; Tot_Drug_Cst)2019 Drug cost: $45,485 (USD; Tot_Drug_Cst)2020 Drug cost: $74,359 (USD; Tot_Drug_Cst)2021 Drug cost: $97,575 (USD; Tot_Drug_Cst)2022 Drug cost: $135,315 (USD; Tot_Drug_Cst)2023 Drug cost: $219,622 (USD; Tot_Drug_Cst)2024 Drug cost: $213,209 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015139364$24,606
20161848$7,694
201736135$16,122
201883202$14,281
2019177605$45,485
2020245873$74,359
20213631,401$97,575
20223701,587$135,315
20236722,603$219,622
20246673,062$213,209

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more247247$113
67028Injection of drug into eye3761,778$89
92014Established patient complete exam of visual system1,1931,765$82
92012Established patient problem focused exam of visual system330392$53
92134Imaging of retina1,4373,148$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate60733,347$40,970
CombiganBrimonidine Tartrate/Timolol843,839$27,295
FluorometholoneFluorometholone21710,978$21,019
IlevroNepafenac471,820$19,812
ProlensaBromfenac Sodium561,938$19,574

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.40$2,718US Oncology Corporate, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Craig Janot, M.D.?

Tedicare shows public-source Medicare data for Adam Craig Janot, M.D. (NPI 1861767147), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Craig Janot, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Craig Janot, M.D.?

Adam Craig Janot, M.D. is linked to VITREORETINAL INSTITUTE, A MEDICAL CORPORATION (billing NPI 1649226580) in the available physician profile data.

Does Adam Craig Janot, M.D. have Open Payments data?

Adam Craig Janot, M.D. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.